Peking University Cancer Hospital & Institute赞助的临床试验
总计18379个结果
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中HER2阳性转移性乳腺癌 | 以前接受过曲妥珠单抗治疗 | 曲妥珠单抗联合帕妥珠单抗和化疗中国
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute主动,不招人
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute主动,不招人
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知癌,非小细胞肺癌 | 多西紫杉醇 | 纳武单抗中国
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute未知
-
Peking University People's HospitalPeking University Cancer Hospital & Institute招聘中
-
Peking University First HospitalPeking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Peking University Third Hospital未知
-
Peking Union Medical College HospitalPeking University; Peking University Cancer Hospital & Institute未知
-
Peking Union Medical College HospitalPeking University; Peking University Cancer Hospital & Institute招聘中
-
Sun YanPeking University; Peking University Cancer Hospital & Institute未知